Quantcast

Latest National Comprehensive Cancer Network Stories

2011-05-24 14:26:00

PITTSBURGH, May 24, 2011 /PRNewswire/ -- D3 Oncology Solutions today announced that it will provide its Via Oncology Pathways for a six-month free trial period to enable cancer programs to align the timing of their investment with a strategy for sharing potential savings with payors and other key stakeholders. (Logo: http://photos.prnewswire.com/prnh/20110524/NE08262LOGO ) Despite the widespread awareness of oncology pathways by oncologists today, the barriers to their adoption stem...

2011-04-07 13:38:00

PITTSBURGH, April 7, 2011 /PRNewswire/ -- Precision Therapeutics, Inc. announced that the launch of a new product line, BioSpeciFx®, will help further the personalization of cancer treatments. BioSpeciFx® is composed of carefully selected sets of well validated and clinically useful biomarker tests that identify critical molecular targets within a patient's cell. By using the information generated by BioSpeciFx® in combination with...

2011-03-01 08:00:00

PITTSBURGH, March 1, 2011 /PRNewswire/ -- D3 Oncology Solutions (D3), formerly D3 Radiation Oncology Solutions, has added Via Oncology Pathways for medical oncology to the company's suite of solutions. With this new offering, D3 now offers integrated pathways programs to both medical and radiation oncology practices across the globe. Via Oncology Pathways are evidence-based clinical algorithms that standardize best practice cancer treatment, optimize patient outcomes, minimize toxicities,...

2011-02-28 11:00:00

Selected abstract points to efficacy of treatment guidelines and need for improved practices CHICAGO, Feb. 28, 2011 /PRNewswire-USNewswire/ -- In their continuing quest to eradicate women's cancers, gynecologic oncologists are developing new approaches to treatment, diagnosis and prevention of these diseases. An outstanding assortment of new research will be on display in Orlando, March 6 - 9, 2011, during the Society of Gynecologic Oncologists' (SGO) 42nd Annual Meeting on Women's Cancer,...

2011-02-11 22:07:30

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute. Although more than 8000 clinical trials are accepting participants, according to the National Cancer Institute (NCI), only an estimated 2%ð”Æ’“š% of newly diagnosed cancer patients participate in them. Prior studies suggest that most...

2011-01-10 14:04:38

Large study offers more accurate diagnosis, guide to genetic testing Researchers have discovered a method for more precise identification of individuals who should undergo testing for genetic mutations of the tumor suppressor gene PTEN, which associates with a variety of conditions including several types of cancers. The research has created a diagnostic scoring system that improves on established criteria. Led by Charis Eng, M.D., Ph.D., Chair of the Genomic Medicine Institute at the Lerner...

2011-01-05 12:00:00

HINSDALE, Ill. and THE WOODLANDS, Texas, Jan. 5, 2011 /PRNewswire/ -- Hinsdale Hematology-Oncology Associates (HHOA), and US Oncology, Inc., a leading integrated oncology company, today announced a new collaboration in Illinois to expand patient access to high-quality, evidence-based cancer care through the United Network of US Oncology. (Logo: http://photos.prnewswire.com/prnh/20100517/DA06089LOGO) Cancer is not a single diagnosis; it is a host of various diseases. Hinsdale...

2011-01-04 09:00:00

THE WOODLANDS, Texas and ASHEVILLE, N.C., Jan. 4, 2011 /PRNewswire/ -- Cancer Centers of North Carolina - Asheville (CCNCA), an affiliate of the United Network of US Oncology with two practices serving North Carolina, today announced that it has implemented iKnowMed(TM) EMR for its electronic medical record (EMR) system. iKnowMed EMR is a product of US Oncology, Inc., a leading integrated oncology company. (Logo: http://photos.prnewswire.com/prnh/20100517/DA06089LOGO) iKnowMed is an...

2010-11-30 08:58:00

MORRISTOWN, N.J. and THE WOODLANDS, Texas, Nov. 30, 2010 /PRNewswire/ -- Hematology Oncology Associates of Northern New Jersey, P.A. (HOANNJ), an independent physician-owned, single-specialty oncology practice with offices in Morristown and Parsippany, and US Oncology, Inc., the nation's leading integrated oncology company, today announced their new collaboration to protect, expand and enhance patient access to high-quality, evidence-based cancer care and clinical research through the...

2010-11-22 09:00:00

DALLAS, Nov. 22, 2010 /PRNewswire/ -- Texas Oncology (http://www.texasoncology.com) is one of the nation's leading cancer treatment networks, offering experienced physicians, advanced technologies, clinical research, and leading-edge treatments to patients in the fight against cancer. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/texas-oncology/46947/ (Photo: http://photos.prnewswire.com/prnh/20101122/MM90540) (Photo:...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related